Altuviiio Kit
Product Images NDC 71104-979

Product Visual Gallery

This gallery contains 53 technical images submitted to the FDA as part of the official labeling for Altuviiio (NDC 71104-979). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bioverativ Therapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Altuviiio 01)

An instructional illustration showing hands peeling back a protective cover from a small round container or vial, likely part of the Altuviiio kit for preparing or administering the medication.*

FDA Label Image

Image (Altuviiio 02)

An instructional diagram illustrating the proper method to connect a spike to a vial. The image shows a hand holding a vial and pushing the spike downward onto the vial top, indicated by arrows and a label pointing to the spike component.*

FDA Label Image

Image (Altuviiio 03)

An instructional illustration showing hands removing a cap from a vial. One hand holds the vial securely while the other lifts the cap straight up, indicating how to open the vial in the ALTUVIIIO kit.*

FDA Label Image

Image (Altuviiio 04)

Instructional diagram showing two hands preparing a medical device: one hand holding a vial or tube and the other hand inserting and twisting a circular disk component onto the top of the vial or tube. This illustration is likely part of directions for assembling or using the ALTUVIIIO kit.*

FDA Label Image

Image (Altuviiio 05)

An instructional illustration showing how to hold and open the ALTUVIIIO kit packaging. It depicts two views of a person's hands interacting with the box, highlighting the top and side panels for opening instructions.*

FDA Label Image

Image (Altuviiio 06)

FDA Label Image

Image (Altuviiio 07)

An instructional diagram showing components of the ALTUVIIIO kit by Bioverativ Therapeutics Inc. Included are a vial adapter, a vial containing powdered medicine, a plunger rod, and a prefilled diluent syringe. The illustration labels each component clearly for assembly or administration guidance.*

FDA Label Image

Image (Altuviiio 08)

An illustrated diagram showing items not included in the ALTUVIIIO kit: an infusion set, tourniquet, alcohol wipes, cotton ball, and a container. Each item is depicted with a simple line drawing and labeled accordingly.*

FDA Label Image

Image (Altuviiio 09)

FDA Label Image

Image (Altuviiio 10)

An instructional illustration showing a vial with liquid and a syringe or injection device. A thermometer icon with an upward arrow indicates the vial should be brought to room temperature before use.*

FDA Label Image

Image (Altuviiio 11)

FDA Label Image

Image (Altuviiio 12)

ALTUVIIIO kit packaging label showing the proprietary name ALTUVIIIO and the nonproprietary name Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl. The label indicates it is a human prescription drug, with Bioverativ Therapeutics Inc. as the labeler. The label also includes dosing and handling instructions, but these are not fully legible in the image.*

FDA Label Image

Image (Altuviiio 13)

FDA Label Image

Image (Altuviiio 14)

An instructional illustration showing two close-up steps for opening a vial. The first step depicts a hand removing a protective cap by pulling it upwards. The second step shows the hand peeling off a seal from the vial's stopper.*

FDA Label Image

Image (Altuviiio 15)

FDA Label Image

Image (Altuviiio 16)

Illustration showing hands removing a peel-off lid from a small plastic container, likely part of a preparation step for the ALTUVIIIO recombinant antihemophilic factor kit.*

FDA Label Image

Image (Altuviiio 17)

FDA Label Image

Image (Altuviiio 18)

An instructional diagram showing how to attach a spike to a vial. The top half illustrates the spike component, and the bottom half demonstrates a hand pressing the spike onto the vial, indicating the correct assembly step for a drug kit.*

FDA Label Image

Image (Altuviiio 19)

An instructional illustration showing a hand removing a cap from a vial. The vial is held by another hand, and a purple arrow indicates the upward motion needed to lift the cap off the vial.*

FDA Label Image

Image (Altuviiio 20)

An instructional illustration showing hands holding components of a medical kit. The top hand holds a small circular disk attached to a twistable tube, indicated by arrows showing a clockwise twisting motion to connect or secure it to the component held by the lower hand, likely part of an assembly step in preparing the ALTUVIIIO kit.*

FDA Label Image

Image (Altuviiio 21)

An illustration showing a hand holding a syringe with a cap and a ridged part identified on the syringe body. The image appears to be instructional, highlighting how to hold or handle the syringe components.*

FDA Label Image

Image (Altuviiio 22)

FDA Label Image

Image (Altuviiio 23)

An instructional illustration showing a hand removing a cap from a vial, with an arrow indicating the cap being lifted upward from the vial's neck. The image highlights the proper method to open the vial for a medication kit.*

FDA Label Image

Image (Altuviiio 24)

FDA Label Image

Image (Altuviiio 25)

An instructional illustration showing two hands assembling or connecting parts of a kit, with one hand holding a vial and the other twisting a syringe or device onto it, indicated by a purple circular arrow for rotation. This likely demonstrates the preparation step for the ALTUVIIIO kit.*

FDA Label Image

Image (Altuviiio 26)

An instructional illustration showing a hand using a syringe to withdraw liquid from a vial by inserting the syringe needle into the vial's rubber stopper, with a directional arrow indicating the downward motion.*

FDA Label Image

Image (Altuviiio 27)

An instructional illustration shows a hand holding a vial and an injection device, demonstrating how to twist or rotate the vial and device together as indicated by purple circular arrows around the vial. The image is intended to guide proper administration or preparation technique for ALTUVIIIO KIT.*

FDA Label Image

Image (Altuviiio 28)

FDA Label Image

Image (Altuviiio 29)

FDA Label Image

Image (Altuviiio 30)

An instructional illustration showing the steps to assemble a syringe and vial adapter. The left panel depicts a hand attaching a syringe to a vial adapter by pressing down. The right panel shows the syringe being pulled downward, likely to draw liquid from the vial. This diagram provides visual guidance on preparation of the ALTUVIIIO kit components for use.*

FDA Label Image

Image (Altuviiio 31)

An instructional illustration showing two hands preparing a syringe or vial. One hand holds a vial with a flip cap being removed, indicated by a purple circular arrow, suggesting the cap is twisted or pulled off. The image likely relates to drug preparation or administration for ALTUVIIIO kit.*

FDA Label Image

Image (Altuviiio 32)

FDA Label Image

Image (Altuviiio 33)

FDA Label Image

Image (Altuviiio 34)

An instructional illustration showing two hands preparing a syringe connected to a tubing set with a three-way stopcock. The upper hand is twisting or fitting the syringe component as indicated by purple arrows.*

FDA Label Image

Image (Altuviiio 35)

FDA Label Image

Image (Altuviiio 36)

An instructional illustration showing the administration of an injection into the inner elbow area (antecubital fossa) of a person's arm. One arm has a blue tourniquet applied above the injection site, while the opposite hand is preparing to insert a needle or syringe into the vein.*

FDA Label Image

Image (Altuviiio 37)

An instructional illustration showing two hands preparing a syringe and vial connection using a tube. The image depicts the assembly step for a medication administration kit, with an upward arrow indicating the direction to connect the components.*

FDA Label Image

Image (Altuviiio 38)

FDA Label Image

Image (Altuviiio 39)

An instructional illustration showing a person's arm with a tourniquet applied above the elbow and a hand inserting a needle into a vein for intravenous access. The image depicts the correct technique for inserting a needle into the arm vein, with one hand stabilizing the arm and the other holding the needle at an angle to the skin.*

FDA Label Image

Image (Altuviiio 40)

FDA Label Image

Image (Altuviiio 41)

An instructional diagram showing a person’s arm with an intravenous line secured by plastic wings. The image highlights the wings and depicts a hand gently pressing or securing the IV line, illustrating proper placement or handling technique for infusion.*

FDA Label Image

Image (Altuviiio 42)

An instructional illustration showing a person administering an injection into the forearm using a syringe and needle connected by tubing to a catheter or IV access point. The image features two hands, with one holding the syringe and the other displaying the injection site with an upward-pointing arrow indicating the direction of injection. No text or branding visible.*

FDA Label Image

Image (Altuviiio 43)

An instructional illustration showing a person cleaning the inner elbow area of the arm with a cotton ball or pad. The image depicts the preparation of the injection site for administering a medication, relevant to the use of a kit dosage form such as ALTUVIIIO.*

FDA Label Image

Image (Altuviiio 44)

An instructional illustration showing a hand holding a syringe attached to a vial or a medical container, positioned above an open red disposal container for safe disposal of needles or sharps.*

FDA Label Image

Image (Altuviiio 45)

FDA Label Image

Image (Altuviiio 46)

ALTUVIIIO kit packaging label showing the proprietary name ALTUVIIIO. The product is an Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl in kit form. The labeler is Bioverativ Therapeutics Inc. The image includes barcode and regulatory information typically found on prescription drug packaging.*

FDA Label Image

Image (Altuviiio 47)

FDA Label Image

Principal Display Panel (250 IU Kit Carton)

Packaging label for ALTUVIIIO 250 IU Nominal kit, containing Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl for intravenous use. The label includes the NDC 71104-978-01, packaging details, manufacturer Bioverativ Therapeutics Inc., a QR code for more information, and instructions to open. It displays the Sanofi logo and highlights contents such as a vial, prefilled diluent syringe, vial adapter, and package insert.*

FDA Label Image

Principal Display Panel (500 IU Kit Carton)

Packaging label for ALTUVIIIO 500 IU Nominal kit, a human prescription drug containing Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl. The label includes usage instructions for intravenous use and manufacturer information for Bioverativ Therapeutics Inc., a Sanofi company. The label also includes a barcode and QR code for more information.*

FDA Label Image

Principal Display Panel (1000 IU Kit Carton)

Packaging label for ALTUVIIIO 1000 IU Nominal, an antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl, for intravenous use. The label displays the proprietary and generic names, dosage strength, NDC 71104-981-01, and indicates a single-dose vial kit with lyophilized powder and sterile diluent syringe. Manufactured by Bioverativ Therapeutics Inc., a Sanofi company, with contact information and storage instructions included.*

FDA Label Image

Principal Display Panel (2000 IU Kit Carton)

Carton packaging label for ALTUVIIIO kit containing Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl. The label specifies a nominal strength of 2000 IU, for intravenous use, and is manufactured by Bioverativ Therapeutics Inc., a Sanofi company. The package includes a single-dose vial, a prefilled diluent syringe, a sterile vial adapter, and a package insert.*

FDA Label Image

Principal Display Panel (3000 IU Kit Carton)

Flat layout of the ALTUVIIIO 3000 IU Nominal kit packaging label for Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl by Bioverativ Therapeutics Inc., a Sanofi company. The label includes dosage strength, NDC 71104-983-01, manufacturer information, barcode, and directions for reconstitution for intravenous use.*

FDA Label Image

Principal Display Panel (4000 IU Kit Carton)

Packaging label for ALTUVIIIO kit containing Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl. The label indicates a nominal potency of 4000 IU and specifies intravenous use. It includes manufacturer information, Bioverativ Therapeutics Inc., a Sanofi company, along with a QR code for more information and detailed contents description for the kit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.